NDC product
Target Eye Drops Maximum Redness Relief Eye
NDC 11673-100 · Target Corporation
Key facts
| Product NDC | 11673-100 |
|---|---|
| Proprietary name | Target Eye Drops Maximum Redness Relief Eye |
| Nonproprietary name | Glycerin, Naphazoline hydrochloride |
| Substances | GLYCERIN, NAPHAZOLINE HYDROCHLORIDE |
| Dosage form | SOLUTION/ DROPS |
| Route | OPHTHALMIC |
| Labeler | Target Corporation |
| Product type | HUMAN OTC DRUG |
| Marketing category | OTC MONOGRAPH DRUG |
| Application number | M018 |
| Pharmacologic classes | Allergens [CS], Cell-mediated Immunity [PE], Glycerol [CS], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Chemical Allergen [EPC] |
| Marketing start | Feb 8, 2019 |
| Listing certified through | Dec 31, 2026 |
At a glance
- 1–9 Package NDCs
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About National Drug Codes (NDC)
The National Drug Code (NDC) is the FDA's product identifier for drugs; the product NDC identifies the labeler and product, and each package adds a package code.
Source: U.S. Food and Drug Administration (FDA), National Drug Code Directory · Source date: